Acurion Completes $4.3M Seed Round

Acurion closed an oversubscribed seed round, raising $4.3 million versus a $4 million target.

The round was led by TK & Partners with participation from multiple venture and research-focused investors.

Acurion’s OncoGaze™ platform uses AI to extract biomarker insights from routine pathology slides without extra tissue or specialized molecular tests.

The company says this approach aims to broaden access to precision oncology by improving biomarker detection and treatment selection.